• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

合并症对COVID-19住院患者死亡率的影响:来自伊朗的经验。

Impact of comorbidities on mortality in hospitalized patients with COVID-19: An experience from Iran.

作者信息

Toofan Firooz, Hosseini Seyed Mojtaba, Alimohammadzadeh Khalil, Jafari Mehrnoosh, Bahadori Mohammadkarim

机构信息

Department of Health Services Management, North Tehran Branch, Islamic Azad University, Tehran, Iran.

Health Management Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran.

出版信息

J Educ Health Promot. 2021 Dec 31;10:460. doi: 10.4103/jehp.jehp_1589_20. eCollection 2021.

DOI:10.4103/jehp.jehp_1589_20
PMID:35233407
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8826893/
Abstract

BACKGROUND

COVID-19 pandemic has spread all over the world. However, information regarding clinical characteristics and prognostic factors is scarce. The aim of this study was to explore the impact of preexistent chronic comorbid conditions and multimorbidity on risk of mortality in patients with COVID-19.

MATERIALS AND METHODS

We designed a retrospective, cross-sectional, observational, single-center study. Data were analyzed from all consecutive patients diagnosed with COVID-19 who admitted in a pandemic hospital affiliated with Tabriz University of Medical Sciences, Tabriz, Iran, from February 20, 2020, to September 25, 2020. The independent effects of preexistent conditions were evaluated using multivariate logistic regression model.

RESULTS

A total of 2597 hospitalized patients with COVID-19 were included. At least one preexistent condition was observed in 36.5% of study population. Multivariate logistic regression analysis showed that older age, male sex, diabetes, cardiovascular disease, hypertension, cancer, chronic kidney diseases, liver diseases, and chronic obstructive pulmonary disease were associated with increased risk of mortality. In addition, the number of comorbidities was significantly associated with increased odds of mortality compared to no-comorbidity.

CONCLUSION

The results of this study suggest that patients with comorbidities have an increased risk of in-hospital mortality following COVID-19 infection.

摘要

背景

新型冠状病毒肺炎疫情已蔓延至全球。然而,关于其临床特征和预后因素的信息却很匮乏。本研究旨在探讨既往慢性合并症和多种合并症对新型冠状病毒肺炎患者死亡风险的影响。

材料与方法

我们设计了一项回顾性、横断面、观察性单中心研究。分析了2020年2月20日至2020年9月25日期间在伊朗大不里士医科大学附属大流行医院收治的所有连续确诊为新型冠状病毒肺炎患者的数据。使用多因素逻辑回归模型评估既往疾病的独立影响。

结果

共纳入2597例住院的新型冠状病毒肺炎患者。36.5%的研究人群存在至少一种既往疾病。多因素逻辑回归分析显示,年龄较大、男性、糖尿病、心血管疾病、高血压、癌症、慢性肾脏病、肝脏疾病和慢性阻塞性肺疾病与死亡风险增加相关。此外,与无合并症相比,合并症的数量与死亡几率增加显著相关。

结论

本研究结果表明,合并症患者在新型冠状病毒肺炎感染后院内死亡风险增加。

相似文献

1
Impact of comorbidities on mortality in hospitalized patients with COVID-19: An experience from Iran.合并症对COVID-19住院患者死亡率的影响:来自伊朗的经验。
J Educ Health Promot. 2021 Dec 31;10:460. doi: 10.4103/jehp.jehp_1589_20. eCollection 2021.
2
Demographics, clinical characteristics, and outcomes of 27,256 hospitalized COVID-19 patients in Kermanshah Province, Iran: a retrospective one-year cohort study.伊朗克尔曼沙阿省 27256 例住院 COVID-19 患者的人口统计学、临床特征和结局:一项回顾性一年队列研究。
BMC Infect Dis. 2022 Mar 31;22(1):319. doi: 10.1186/s12879-022-07312-7.
3
Epidemiological characteristics of coronavirus disease 2019 (COVID-19) patients in IRAN: A single center study.伊朗 2019 冠状病毒病(COVID-19)患者的流行病学特征:一项单中心研究。
J Clin Virol. 2020 Jun;127:104378. doi: 10.1016/j.jcv.2020.104378. Epub 2020 Apr 21.
4
Association of pre-existing comorbidities with mortality and disease severity among 167,500 individuals with COVID-19 in Canada: A population-based cohort study.在加拿大,167500 例 COVID-19 患者中,先前存在的合并症与死亡率和疾病严重程度的关系:一项基于人群的队列研究。
PLoS One. 2021 Oct 5;16(10):e0258154. doi: 10.1371/journal.pone.0258154. eCollection 2021.
5
Age and Multimorbidity Predict Death Among COVID-19 Patients: Results of the SARS-RAS Study of the Italian Society of Hypertension.年龄和多种合并症预测 COVID-19 患者的死亡:意大利高血压学会 SARS-RAS 研究的结果。
Hypertension. 2020 Aug;76(2):366-372. doi: 10.1161/HYPERTENSIONAHA.120.15324. Epub 2020 Jun 22.
6
7
Determinants of COVID-19 disease severity in patients with underlying rheumatic disease.风湿性疾病患者 COVID-19 疾病严重程度的决定因素。
Clin Rheumatol. 2020 Sep;39(9):2789-2796. doi: 10.1007/s10067-020-05301-2. Epub 2020 Jul 27.
8
Multimorbidity and SARS-CoV-2-Related Outcomes: Analysis of a Cohort of Italian Patients.多病症与 SARS-CoV-2 相关结局:意大利患者队列分析。
JMIR Public Health Surveill. 2023 Feb 9;9:e41404. doi: 10.2196/41404.
9
Role of comorbidities on the mortality in patients with SARS-CoV-2 infection: an Italian cohort study.合并症对新型冠状病毒2感染患者死亡率的影响:一项意大利队列研究。
Minerva Med. 2023 Apr;114(2):185-190. doi: 10.23736/S0026-4806.21.07187-1. Epub 2021 Apr 29.
10
Evaluation of the frequency and intensity of COVID-19 in patients with ankylosing spondylitis under anti-TNF therapy.评估抗 TNF 治疗的强直性脊柱炎患者 COVID-19 的频率和强度。
Turk J Med Sci. 2022 Apr;52(2):522-523. doi: 10.55730/1300-0144.5341. Epub 2022 Apr 14.

引用本文的文献

1
Survival, mortality and epidemic risk status of COVID-19: a population-based Study in Golestan province, Iran.新型冠状病毒肺炎的生存、死亡率及流行风险状况:伊朗戈勒斯坦省的一项基于人群的研究
Arch Public Health. 2024 Jul 8;82(1):105. doi: 10.1186/s13690-024-01330-4.
2
Influence of simultaneous comorbidities on COVID-associated acute respiratory distress syndrome mortality in people with diabetes.合并症对糖尿病患者新冠相关急性呼吸窘迫综合征死亡率的影响。
J Taibah Univ Med Sci. 2024 Mar 21;19(3):492-499. doi: 10.1016/j.jtumed.2024.03.006. eCollection 2024 Jun.
3
Individual and mutual effects of diabetes, hypertension, and obesity on acute respiratory distress syndrome mortality rates in clinical patients: a multicentre study.

本文引用的文献

1
Effects of COVID-19 pandemic lockdown on medical advice seeking and medication practices of home-bound non-COVID patients.新冠疫情封锁对居家非新冠患者寻求医疗建议及用药行为的影响。
J Educ Health Promot. 2021 Jan 28;10:28. doi: 10.4103/jehp.jehp_481_20. eCollection 2021.
2
Social influence of COVID-19: An observational study on the social impact of post-COVID-19 lockdown on everyday life in Kerala from a community perspective.新冠疫情的社会影响:从社区视角对喀拉拉邦解除新冠疫情封锁后对日常生活的社会影响进行的观察性研究。
J Educ Health Promot. 2020 Dec 29;9:360. doi: 10.4103/jehp.jehp_650_20. eCollection 2020.
3
Risk Factors Associated With In-Hospital Mortality in a US National Sample of Patients With COVID-19.
个体和相互作用的糖尿病、高血压和肥胖对临床患者急性呼吸窘迫综合征死亡率的影响:一项多中心研究。
Front Public Health. 2023 Jun 21;11:1219271. doi: 10.3389/fpubh.2023.1219271. eCollection 2023.
4
Risk Factors Associated with Severity and Death from COVID-19 in Iran: A Systematic Review and Meta-Analysis Study.伊朗 COVID-19 严重程度和死亡的相关风险因素:系统评价和荟萃分析研究。
J Intensive Care Med. 2023 Sep;38(9):825-837. doi: 10.1177/08850666231166344. Epub 2023 Mar 28.
5
SARS-CoV2 Infection and Comorbidity in Inmates: A Study of Central Italy.SARS-CoV2 感染与囚犯共病:意大利中部的一项研究。
Int J Environ Res Public Health. 2023 Feb 9;20(4):3079. doi: 10.3390/ijerph20043079.
6
Identifying the preparedness components in COVID-19: Systematic literature review.确定2019冠状病毒病的防范要素:系统文献综述
J Educ Health Promot. 2022 Nov 26;11:385. doi: 10.4103/jehp.jehp_28_22. eCollection 2022.
与美国 COVID-19 患者住院死亡率相关的风险因素。
JAMA Netw Open. 2020 Dec 1;3(12):e2029058. doi: 10.1001/jamanetworkopen.2020.29058.
4
Clinical Characteristics and Outcomes of 905 COVID-19 Patients Admitted to Imam Khomeini Hospital Complex in the Capital City of Tehran, Iran.德黑兰首都伊玛目霍梅尼医院综合大楼 905 例 COVID-19 患者的临床特征和结局。
Arch Iran Med. 2020 Nov 1;23(11):766-775. doi: 10.34172/aim.2020.102.
5
Comorbidities, Cardiovascular Therapies, and COVID-19 Mortality: A Nationwide, Italian Observational Study (ItaliCO).合并症、心血管治疗与新冠病毒疾病死亡率:一项意大利全国性观察性研究(ItaliCO)
Front Cardiovasc Med. 2020 Oct 9;7:585866. doi: 10.3389/fcvm.2020.585866. eCollection 2020.
6
Intermediate versus standard-dose prophylactic anticoagulation and statin therapy versus placebo in critically-ill patients with COVID-19: Rationale and design of the INSPIRATION/INSPIRATION-S studies.COVID-19 重症患者中中剂量与标准剂量预防性抗凝和他汀类药物治疗与安慰剂对照的研究:INSPIRATION/INSPIRATION-S 研究的原理和设计。
Thromb Res. 2020 Dec;196:382-394. doi: 10.1016/j.thromres.2020.09.027. Epub 2020 Sep 24.
7
Early predictors of in-hospital mortality in patients with COVID-19 in a large American cohort.大型美国队列研究中 COVID-19 患者院内死亡的早期预测因素。
Intern Emerg Med. 2020 Nov;15(8):1485-1499. doi: 10.1007/s11739-020-02509-7. Epub 2020 Sep 24.
8
Association of cardiovascular disease and 10 other pre-existing comorbidities with COVID-19 mortality: A systematic review and meta-analysis.心血管疾病与其他 10 种预先存在的合并症与 COVID-19 死亡率的关联:系统评价和荟萃分析。
PLoS One. 2020 Aug 26;15(8):e0238215. doi: 10.1371/journal.pone.0238215. eCollection 2020.
9
Risk Factors Associated With Mortality Among Patients With COVID-19 in Intensive Care Units in Lombardy, Italy.意大利伦巴第地区重症监护病房中 COVID-19 患者死亡的相关危险因素。
JAMA Intern Med. 2020 Oct 1;180(10):1345-1355. doi: 10.1001/jamainternmed.2020.3539.
10
Age and Multimorbidity Predict Death Among COVID-19 Patients: Results of the SARS-RAS Study of the Italian Society of Hypertension.年龄和多种合并症预测 COVID-19 患者的死亡:意大利高血压学会 SARS-RAS 研究的结果。
Hypertension. 2020 Aug;76(2):366-372. doi: 10.1161/HYPERTENSIONAHA.120.15324. Epub 2020 Jun 22.